跳至主要内容
临床试验/NCT06991049
NCT06991049招募中不适用

Early Versus Late Endoscopic Temporary Stenting for Management of Refractory Benign Esophageal Strictures

Medical College of Wisconsin1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2025年10月14日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
20
试验地点
1
主要终点
Time to achieve esophageal luminal diameter to ≥14 mm

研究概览

简要总结

This project is being done to compare two current treatment clinical options for management of RBES: 1) Frequent dilations followed by temporary esophageal stent placement if dilations fail, or 2) Early stent placement followed by dilations

详细描述

This study aims to explore the safety and effectiveness of two clinical treatment approaches used to manage RBES patients-Temporary early-stent placement versus late stenting.

For normal swallowing, the esophagus (food pipe) lumen should be equal to or more than 14 mm in diameter. In those with stricture (narrowing) of the esophagus from benign causes, initial endoscopic management is serial sessions of dilation (stretching) to achieve and maintain a diameter of ≥14mm. Many strictures may not respond to this approach (refractory). Esophageal stents (18 mm - 23 mm diameter) temporarily placed for 2 weeks using an endoscope are also used dilate and remold the stricture. While in place, patients can swallow. This can save the patient from undergoing repeated dilations. Stents can be placed either late in the process of management after several traditional dilations have failed or early in the management to rapidly achieve a diameter of ≥14 mm and then continuing traditional dilations.

Although either of above two approaches can be used for the clinical management of RBES, in this study the investigators plan to randomly assign patients to start with one of the two approaches and compare outcomes.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Able to give informed and written consent.
  • •Able to keep follow up appointments as per protocol (minimum 2 years).
  • •Biopsy proven benign esophageal stricture.
  • •Dysphagia (grade 2 and above).
  • •Fit to undergo upper GI endoscopy.
  • •Documented esophageal stricture with a luminal diameter <14 mm at index endoscopy.

排除标准

  • •Minimal dysphagia (grade 0-1)
  • •Neuromuscular dysphagia (such as achalasia, oro-pharyngeal dysphagia post-stroke, crico-pharyngeal bar, Zenker diverticulum etc.)
  • •Pregnant or planning to be pregnant during the study period.
  • •Malignant or indeterminate esophageal stricture.
  • •Actively receiving radiation therapy.
  • •Persistent associated active esophagitis that has not yet healed.
  • •Esophageal strictures associated with fistula/leaks/current or prior perforation.
  • •Eosinophilic esophagitis.
  • •Associated esophageal varices.
  • •No other malignancy limiting life expectancy.
  • •Patients in whom placing esophageal stents is not possible/contraindicated (such as high cervical esophageal strictures, active bleeding, metal allergy, tortuous esophagus, pseudodiverticulum with stricture).
  • •Previous esophageal stent tried over 2 months ago
  • •Significant comorbidities making patient high risk for upper GI endoscopy.
  • •Unable to give informed consent.
  • •Cannot keep follow up appointments as per protocol.
  • •Procedures and stents not covered by patient's insurance.
  • •Patients who, after comprehensive discussion and explanation of both the early-stent and late-stent approaches, choose to proceed with a specific approach and decline participation in randomization.

研究组 & 干预措施

Late-stent approach

Active Comparator

Repeated dilations at weekly intervals, and based on the response, the intervals between dilations are adjusted, and if still no response, place a removable FCSEMS (18 mm diameter). The stent will be removed in 2 weeks followed again by weekly dilations till less than one dilation is needed every 3 months to maintain a luminal diameter of 14 mm or more.

干预措施: Fully covered self-expandable metal esophageal stent (Device)

Early-stent approach

Active Comparator

Removable FCSEMS (18 mm diameter) placed on index endoscopy and removed after 2 weeks followed by weekly dilations till less than one dilation is needed every 3 months to maintain a luminal diameter of 14 mm or more.

干预措施: Fully covered self-expandable metal esophageal stent (Device)

结局指标

主要结局

Time to achieve esophageal luminal diameter to ≥14 mm

时间窗: From enrollment to follow up, up to 2 years

The duration required to achieve and maintain an esophageal diameter of ≥14 mm using the two techniques.

次要结局

  • Adverse event rate(From enrollment to follow up, up to 2 years)
  • Recurrence rate of esophageal stricture(From enrollment to follow up, up to 2 years)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Kulwinder Dua, MD

Professor of Medicine

Medical College of Wisconsin

研究点 (1)

Loading locations...

相似试验